pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
XYA-01
Triple-Negative Breast Cancer (TNBC)
Xyone Therapeutics Inc
0
catalysts
Preclinical
XYA-02
Pancreatic Ductal Adenocarcinoma
Xyone Therapeutics Inc
0
catalysts
Phase 2
XmAb bispecific antibody
Unspecified Cancer
$NVS
NOVARTIS AG
0
catalysts
Preclinical
YB-200
Hepatocellular Carcinoma
← prev
page 39 of 62
next →
131
Pain
89
Neurology
1
Ymmunobio AG
0
catalysts
Phase 1
YENEO-001
Colorectal Cancer
NantBio Inc
0
catalysts
Phase 1
YH-013
Solid Tumor
Eucure (Beijing) Biopharma Co Ltd
0
catalysts
Phase 2
YH-42946
Non-Small Cell Lung Cancer
Yuhan Corp
0
catalysts
Phase 2
YL-13027
Solid Tumor
Shanghai Yingli Pharmaceutical Co Ltd
0
catalysts
Phase 2
YL-15293
Colorectal Cancer
Shanghai Yingli Pharmaceutical Co Ltd
0
catalysts
Phase 1
YL-217
Colorectal Cancer
Suzhou Medilink Therapeutics Ltd
0
catalysts
Marketed
Yonsa
Yonsa (abiraterone acetate)
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Sun Pharmaceutical Industries Ltd
0
catalysts
Phase 2
ZEN-3694
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Zenith Epigenetics Ltd
0
catalysts
Phase 1
ZH9
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
Prokarium Ltd
0
catalysts
Preclinical
ZL-1311
Gastric Cancer
$ZLAB
Zai Lab Ltd
0
catalysts
Phase 1
ZL-6201
Breast Cancer
$ZLAB
Zai Lab Ltd
0
catalysts
Phase 1
ZM-008
Bile Duct Cancer (Cholangiocarcinoma)
Zumutor Biologics Inc
0
catalysts
Phase 1
ZW-191
Endometrial Cancer
$ZYME
Zymeworks Inc.
0
catalysts
Phase 1
ZW-251
Hepatocellular Carcinoma
$ZYME
Zymeworks Inc.
0
catalysts
Phase 2
abefolastat tesaroxetan
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Clarity Pharmaceuticals Ltd
0
catalysts
Marketed
abemaciclib
Verzenio (abemaciclib)
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Eli Lilly and Co
0
catalysts
Phase 2
abequolixron zinc
Epithelial Ovarian Cancer
Inspirna Inc
0
catalysts
Phase 3
abexinostat
Metastatic Renal Cell Carcinoma
Histone deacetylase
Xynomic Pharmaceuticals Holdings Inc
0
catalysts
Phase 2
acimtamig
acimtamig [INN]
Anaplastic Large Cell Lymphoma (ALCL)
Affimed GmbH
0
catalysts
Phase 2
actinium (225Ac) lintuzumab satetraxetan
Actimab A (actinium (225Ac) lintuzumab satetraxetan [INN])
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
$ATNM
Actinium Pharmaceuticals, Inc.
0
catalysts
Marketed
adagrasib
Krazati (adagrasib)
Non-Small Cell Lung Cancer
GTPase KRas
Bristol-Myers Squibb Co
0
catalysts
Phase 2
adrixetinib
adrixetinib [INN]
Solid Tumor
Qurient Co Ltd
0
catalysts
Phase 2
afamitresgene autoleucel
Tecelra (afamitresgene autoleucel)
Myxoid Liposarcoma
Melanoma-associated antigen 4
US WorldMeds LLC
0
catalysts
Preclinical
afatinib + palbociclib
afatinib [INN] + palbociclib
Chordoma
Collaborations Pharmaceuticals Inc
0
catalysts
Marketed
afatinib dimaleate
Gilotrif (afatinib dimaleate)
Non-Small Cell Lung Cancer
Boehringer Ingelheim Corp
0
catalysts
Phase 3
afuresertib hydrochloride
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Laekna Inc
0
catalysts
